AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 47th Annual Global Healthcare Conference at 9:20 a.m. ET on Tuesday, June 9, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 47th Annual Global Healthcare Conference at 9:20 a.m. ET on Tuesday, June 9, 2026. Executives Peter Griffith and Murdo Gordon will speak, with a live webcast and replay available via Amgen's investor relations website.
Details
News Market Reaction – AMGN
On Jun 5, the first trading day after this news, AMGN closed 1.15% above the previous close.
Data tracked by StockTitan Argus for the Jun 5 session.
Key Figures
- Conference edition
- 47th
- Goldman Sachs Annual Global Healthcare Conference
- Presentation time
- 9:20 a.m. ET
- Scheduled slot on Tuesday, June 9, 2026
- Event date
- June 9, 2026
- Goldman Sachs Global Healthcare Conference appearance
- Webcast archive period
- 90 days
- Replay availability after the event
Historical Context
-
New Phase 3 and real-world data across rare autoimmune diseases.
-
Management presentation at major healthcare investor conference.
-
Amgen Ventures participation in Ember LifeSciences Series A round.
-
Announcement of CFO retirement and planned successor transition.
-
Investor conference presentation featuring CFO and R&D leadership.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.
More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions.
Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads.
CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media)
Casey Capparelli, 805-447-1746 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-302791943.html
SOURCE Amgen
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.